AEMPS tightens the screw on Spanish medtech market
This article was originally published in Clinica
Spanish firms seeking to enter the medical device market faced continued pressure from the regulator last year, in terms of the tight requirements imposed on them, but there was significant growth in the number of firms who sought to amend their registration. This is one of the highlights of the 2008 regulatory activities report of the national medicines and healthcare products agency (AEMPS), as Competent Authority.
You may also be interested in...
UK start up Iceni Diagnostics has secured funding to develop its test for the live, intact SARS-CoV-2 virus and the UK government is evaluating a lateral flow device based on the technology for testing saliva samples as part of efforts to step up rapid testing in the country.
As Bharat Biotech prepares its COVID-19 vaccine for a launch in the quarter ending next 30 September and claims at least 60% efficacy, questions arise over why trials were not temporarily halted following a serious adverse event during Phase I and why this wasn’t disclosed to participants in subsequent studies.
Highlighting progress it has made over the past few years, Japan’s regulatory agency says it wants to raise even further the number of “Japan-first” approvals, as part of its stated mission to get safe and effective new drugs to patients more quickly.